29 Aug, 2022 CereVasc Announces First Patient Treated in U.S. Pilot Trial Evaluating the eShunt System in Patients with Normal Pressure Hydrocephalus Admin2023-11-06T21:52:45+00:00August 29th, 2022| Read More
09 Aug, 2022 CereVasc Announces FDA Approval of Second IDE Study of the eShunt® System Admin2023-11-06T21:48:30+00:00August 9th, 2022| Read More
25 Apr, 2022 First patient treated in CereVasc® clinical trial of eShunt® System for Normal Pressure Hydrocephalus Admin2023-11-06T21:37:10+00:00April 25th, 2022| Read More
08 Feb, 2022 CereVasc Receives FDA IDE Approval to Begin Initial Clinical Study of the eShunt® System for Patients with Normal Pressure Hydrocephalus Admin2023-11-06T21:21:09+00:00February 8th, 2022| Read More
07 Dec, 2021 CereVasc Announces Publication of First-in-Human Case Report of its eShunt System for the Treatment of Communicating Hydrocephalus Admin2023-11-06T21:13:31+00:00December 7th, 2021| Read More
03 Dec, 2021 First-in-human endovascular treatment of hydrocephalus with a miniature biomimetic transdural shunt Admin2023-12-20T22:33:01+00:00December 3rd, 2021| Read More
08 Apr, 2021 Case 10-2021: A 70-Year-Old Man with Depressed Mood, Unsteady Gait, and Urinary Incontinence Admin2023-12-19T22:48:26+00:00April 8th, 2021| Read More
29 May, 2020 Readmission and reoperation for hydrocephalus: a population-based analysis across the spectrum of age Admin2023-12-20T21:56:17+00:00May 29th, 2020| Read More
16 Jan, 2017 Forty years of shunt surgery at Rigshospitalet, Denmark: a retrospective study comparing past and present rates and causes of revision and infection Admin2023-12-20T21:55:31+00:00January 16th, 2017| Read More